X
About Solutions Approach Contact
News & Resources Login
Whitepaper

Aided by the Orphan Drug Act of 1983, biotech and pharma companies have sought development treatments for the approximately 7,000 rare diseases that have been identified.

Download Feb 19, 2018
Whitepaper

In order to successfully commercialize a rare disease product, manufacturers must consider the needs of multiple stakeholders.

Download Feb 15, 2018
Press Release

McKesson Corporation, a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of RxCrossroads. 

Read More Jan 03, 2018
Press Release

McKesson Corporation today announced that it has signed a definitive agreement to purchase RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health Corporation.

Read More Nov 08, 2017
Newsletter

RxCrossroads' third quarter legislative brief of 2017 is now available. Learn more about recent reimbursement and coverage policy updates.

Download Sep 22, 2017
Newsletter

RxCrossroads' second quarter legislative brief of 2017 is now available. Learn more about recent reimbursement and coverage policy updates.

Download May 30, 2017